Review paper
Vascular Cardio-Oncology: Vascular Endothelial Growth Factor inhibitors and hypertension
Abstract
Since the formation of new blood vessels is essential for tumour growth and metastatic spread, inhibition of angiogenesis by targeting the vascular endothelial growth factor (VEGF) pathway is an effective strategy for various types of cancer, most importantly renal cell carcinoma, thyroid cancer, and hepatocellular carcinoma. However, VEGF inhibitors have serious side effects, most importantly hypertension and nephropathy. In case of fulminant...
Paper Details
Title
Vascular Cardio-Oncology: Vascular Endothelial Growth Factor inhibitors and hypertension
Published Date
Jan 25, 2019
Journal
Volume
115
Issue
5
Pages
904 - 914